Researchers have uncovered strong evidence that major depressive disorder (MDD) plays a significant role in worsening asthma outcomes among older adults. Researchers noted that the findings from their study, “Longitudinal Pathways Between Major Depressive Disorder and Asthma Outcomes in Older Adults,” highlight the importance of addressing emotional health as a core component of asthma management for aging populations. They study was published in The Journal of Allergy and Clinical Immunology: In Practice.
The study focused on a vulnerable population already facing dual challenges. According to the study’s authors, older adults are known to be at heightened risk for both depression and severe asthma complications. The study followed 336 participants aged 60 and older in New York City. Over an 18‑month period, researchers collected detailed clinical data, including depressive symptoms, inhaled corticosteroid (ICS) adherence, asthma beliefs, symptom control, medication use and health care utilization.
One of the most striking findings, the authors noted, was the strong connection between MDD and negative emotional beliefs about asthma. Participants with depression tended to perceive their condition as more threatening and emotionally burdensome. These distorted beliefs translated into worse adherence to inhaled corticosteroid therapy — the cornerstone of asthma management. Patients with MDD demonstrated significantly lower adherence as captured by electronic medication monitors.
The consequences of these emotional and behavioral patterns, researchers said, were reflected in health care outcomes. Older adults with MDD experienced more frequent emergency department (ED) visits over the study period, highlighting the real-world impact of untreated or undertreated depression in chronic disease management.
Researchers used latent variable structural equation modeling to identify mediating pathways between depression and asthma progression. In addition to lower adherence to asthma medicine and increased visits to the ED, the negative beliefs about asthma were found to mediate other poor outcomes, including:
- Lower quality of life
- More oral corticosteroid (OCS) bursts (the use of short-term, three- to 10-day courses of high-dose steroids to quickly treat asthma attacks, COPD flares or intense allergic reactions)
- Higher hospitalization rates
These results underscore the extent to which perception and emotional response — not just physical symptoms — shape long‑term disease trajectories, the researchers wrote. Authors further noted that emotional reactions and beliefs about asthma represent critical intervention targets. For clinicians, integrating mental health support into asthma care plans for older adults may significantly improve medication adherence, reduce exacerbations and lower emergency health care use, they said.
